Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
  Pharmaceutical Technology Europe E-Alert
 
2 November 2012

IN THIS ISSUE
Roche investigated
Ben Venue production
Cell-based therapies
Dr Reddy's & OctoPlus
Watson & Actavis
Twitter

 
Roche Under EMA Investigation
The European Medicines Agency has launched an infringement procedure against Roche to investigate the alleged pharmacovigilance deficiencies that were uncovered during an inspection earlier this year. More...
 
Ben Venue Resumes Limited Production
Ben Venue Laboratories has resumed production on a limited number of manufacturing lines in the company’s Bedford, Ohio, facilities in the US. More...
 
Europe Establishes First Facility for Cell-Based Therapeutics
A consortium in France has announced the establishment of Europe’s first ever industrial manufacturing facility dedicated to the large-scale production of novel, advanced cell-based therapy medicinal products. More...
 
Dr. Reddy's Announces Plans to Acquire OctoPlus for EUR 27 Million
Dr. Reddy's is planning to acquire the specialty injectable company OctoPlus for approximately EUR 27.4 million ($35.7 million) in cash to strengthen its technological capabilities in drug delivery. More...
 
Watson Receives Clearance for Actavis Acquisition
Watson Pharmaceuticals has received clearance from the Federal Trade Commission for its acquisition of the generic drug manufacturer, Actavis, for $5.6 billion. More...
 
Get the Latest Updates on Twitter
We regularly tweet the latest news and rumours hitting the web about the pharmaceutical industry. Follow us to keep up to date. More...
Key Topics:

Latest blog posts
Eli Lilly Chariman Stresses the Importance of Biopharmaceutical Innovation on the Economy
FDA Reg. Science Initiative Moving Along with Academic Help
Recognising Pharma Innovation
More blog posts

Latest articles
Supplier Qualification
Integration of Less-Formal Risk Assessment Tools into Change Control
Seeking Solutions in Solid-State Chemistry
More articles

Upcoming events
Lab Innovations 2012 (7–8 November | UK)
BioEurope 2012 (12–14 November | Germany)
The GMP Compliance Manager (15–16 November | Hungary)
More events

Products/Service Profiles
Nisso America


Event profile

Lab Innovations
.

Survey
Do you think the growing number of anticounterfeiting technologies, coupled with increased focus from regulators, have had a positive impact on reducing the number of counterfeit pharmaceuticals in the legal supply chain?
 
Yes 53%
 
 
No 14%
     
 
Technologies have; regulations are still inadequate 26%
     
 
Regulations have; technologies are still inadequate 7%

This week we would like to know...

Concerns have recently been raised about the safety of confidential data at FDA. Do you think regulators are doing enough to protect confidential data?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.